MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
EBS Emergent BioSolutions
- 8.100
- +0.040+0.50%
Close Dec 20 16:00 ET
- 8.100
- 0.0000.00%
Post 20:01 ET
438.89MMarket Cap-2.07P/E (TTM)
8.350High7.700Low2.50MVolume7.850Open8.060Pre Close20.30MTurnover4.70%Turnover RatioLossP/E (Static)54.18MShares15.10052wk High0.86P/B430.85MFloat Cap1.42052wk Low--Dividend TTM53.19MShs Float137.610Historical High--Div YieldTTM8.07%Amplitude1.420Historical Low8.122Avg Price1Lot Size
About Emergent BioSolutions Company
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.
Company Profile
SymbolEBS
Company NameEmergent BioSolutions
Listing DateOct 2, 2009
Issue Price12.50
Founded1998
CEOMr. Joseph C. Papa
MarketNYSE
Employees1600
Fiscal Year Ends12-31
Address300 Professional Drive,Suite 400
CityGaithersburg
ProvinceMaryland
CountryUnited States of America
Zip Code20879
Phone1-240-631-3200
Company Executives
- Name
- Position
- Salary
- Joseph C. Papa
- Director, President and Chief Executive Officer
- --
- Richard S. Lindahl
- Principal Accounting Officer, Executive Vice President, Chief Financial Officer and Treasurer
- 2.18M
- Coleen Glessner
- Executive Vice President, Quality and Ethics and Compliance
- 1.68M
- Paul Williams
- Senior Vice President, Products Business
- 1.06M
- Dr. Zsolt Harsanyi,PhD
- Chairman of the Board
- 535.98K
- Sujata Dayal
- Director
- 382.23K
- Marvin L. White
- Independent Director
- 405.98K
- Dr. Louis W. Sullivan, M.D.
- Independent Director
- 400.23K
- Neal F. Fowler
- Independent Director
- 398.75K
- Dr. Kathryn C. Zoon, PhD
- Independent Director
- 413.48K
- Keith A. Katkin
- Independent Director
- 396.99K
- Donald W. DeGolyer
- Independent Director
- 397.50K
- Ronald B. Richard
- Independent Director
- 394.73K
- General George A. Joulwan
- Independent Director
- 41.83K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
